Table 2: The mean central macular thicknesses over time of all patients included in the study.
Time from First Injection
Mean Central Macular Thickness (µm)
12 months prior
326
Day of First Injection
340
3 months after
326
6 months after
328
9 months after
400
12 months after
344
18 months after
353
More than 18 months after
436
The macular thickness results are taken from optical coherence tomography images and are partitioned based on days prior to or following the initial treatment with intravitreal bevacizumab.